Hansen readies stock offering
An imaging center from New York has entered the RadNet fold and another nine from New Jersey are on deck to do so. The acquisitions will extend the company's imaging center net in the Mid-Rockland region and promise a $20 million boost in annual revenues. Inter-County Imaging of Yonkers, NY, is already onboard as the result of a deal made with Medical Resources, which has signed definitive purchase agreements with RadNet to sell nine additional centers in New Jersey. The pending deals are expected to close around May 31. RadNet is acquiring the assets, excluding working capital, but no debts or liabilities held by the centers, for a cash price of $2.65 million.
Robotic surgery specialist Hansen Medical hopes to net more than $35 million through a common stock offering of 11.7 million shares at $3.055 per share. The offering is expected to settle by April 22.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.